Cargando…
Group testing performance evaluation for SARS-CoV-2 massive scale screening and testing
BACKGROUND: The capacity of the current molecular testing convention does not allow high-throughput and community level scans of COVID-19 infections. The diameter in the current paradigm of shallow tracing is unlikely to reach the silent clusters that might be as important as the symptomatic cases i...
Autor principal: | Nalbantoglu, Ozkan Ufuk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330001/ https://www.ncbi.nlm.nih.gov/pubmed/32615934 http://dx.doi.org/10.1186/s12874-020-01048-1 |
Ejemplares similares
-
COVID-19 Pandemic: Group Testing
por: Nalbantoglu, Ozkan Ufuk, et al.
Publicado: (2020) -
Qualitative monitoring of SARS-CoV-2 mRNA vaccination in humans using droplet microfluidics
por: Broketa, Matteo, et al.
Publicado: (2023) -
HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system
por: Frayle, Helena, et al.
Publicado: (2019) -
Group testing can improve the cost-efficiency of prospective-retrospective biomarker studies
por: Zhang, Wei, et al.
Publicado: (2021) -
Sample-to-Answer and Routine Real-Time RT-PCR: A Comparison of Different Platforms for SARS-CoV-2 Detection
por: Wen, Donghua, et al.
Publicado: (2021)